Kewalramani Reshma
CEO & PresidentSEC Form 4 insider transaction history, parsed and scored by FilingIQ.
Total trades
48
Last 180 days
13
Avg composite
72.6
Last trade
Feb 27, 2026
Recent tickers traded
Latest filings by Kewalramani Reshma
VRTX VERTEX PHARMACEUTICALS INC / MA
P Aug 6, 2025
VRTX VERTEX PHARMACEUTICALS INC / MA
S Nov 8, 2024
VRTX VERTEX PHARMACEUTICALS INC / MA
S Jul 30, 2024
VRTX VERTEX PHARMACEUTICALS INC / MA
S Jul 22, 2024
VRTX VERTEX PHARMACEUTICALS INC / MA
S May 20, 2024
Most recent disclosures. Sign up to filter by score, transaction code, or company.
Activity overview
FilingIQ has scored 48 SEC Form 4 insider transactions associated with Kewalramani Reshma. The most recent transaction is dated Feb 27, 2026.
Frequently asked
- How many Form 4 transactions has Kewalramani Reshma filed?
- FilingIQ has indexed 48 SEC Form 4 insider transactions associated with Kewalramani Reshma. The most recent transaction is dated Feb 27, 2026. Every filing sources back directly to SEC EDGAR.
- What is Kewalramani Reshma's average composite score?
- Kewalramani Reshma's average FilingIQ composite score is 72.6/100, produced by the FilingIQ multi-factor Form 4 model. The model framework is documented at /methodology.
- Which companies has Kewalramani Reshma traded?
- Most recent trading activity covers DNA, VRTX. The full Form 4 history including older issuers is available on the FilingIQ web app.
- Where does FilingIQ's insider data come from?
- Every Form 4 transaction shown on this page is parsed directly from SEC EDGAR XML filings. Insider identity is normalized across CIK changes, name spellings, and indirect / related-party reporting.
Methodology & sources
All Form 4 transactions parsed directly from public SEC EDGAR XML filings. The FilingIQ composite score is documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.